Zobrazeno 1 - 10 of 187 pro vyhledávání: '"W, Eschner"'
1
EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases
Autor: W. Eschner, Markus Luster, Glenn D. Flux, Michael Lassmann, Heribert Hänscheid, Cristina Canzi, Lidia Strigari
Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging. 40:1126-1134
The EANM Dosimetry Committee Series "Standard Operational Procedures for Pre-Therapeutic Dosimetry" (SOP) provides advice to scientists and clinicians on how to perform patient-specific absorbed dose assessments. This particular SOP describes how to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5999eccce33be3fe185e09783400be2f
https://doi.org/10.1007/s00259-013-2387-x
Zobrazit plný text záznamu
2
PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposure
Autor: Markus Dietlein, W. Eschner, Harald Schicha, Matthias Schmidt
Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging. 37:131-135
To evaluate the impact of the reduced life expectancy of patients (compared to a nonpatient group with the same age distribution) on their nominal risk of developing cancer from the diagnostic use of radiation.We define a "prognosis-based lifetime at
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d55625cdac9a49ae0e1ee2345779ade9
https://doi.org/10.1007/s00259-009-1221-y
Zobrazit plný text záznamu
3
Radiation exposure in the environment of patients after application of radiopharmaceuticals
Autor: W. Eschner, Carsten Kobe, Harald Schicha, Jochen Hammes, F. Boldt, F. Sudbrock
Publikováno v: Nuklearmedizin. 48:17-25
Summary Aim: After therapeutical application of radionuclides the patient has to be regarded as a radioactive source. The radiation exposure differs from diagnostic nuclear medicine due to the amount of radioactivity and due to β-radiation. Measurem
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee1baf71d27609a20356beaf607d1b00
https://doi.org/10.3413/nukmed-0193
Zobrazit plný text záznamu
4
Radiation exposure in the environment of patients after application of radiopharmaceuticals
Autor: C. Kobe, F. Sudbrock, H. Schicha, F. Boldt, W. Eschner
Publikováno v: Nuklearmedizin. 47:267-274
Ziel: Die Anwendung radioaktiver Substanzen am Menschen ist mit einer Strahlenexposition in der Umgebung des Patienten verbunden. Die Arbeit gibt anhand eigener Messungen einen breiten Uberblick der auftretenden Photonendosisleistungen in Abhangigkei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c45c77b22231d287b82261f61beaacfe
https://doi.org/10.3413/nukmed-0184
Zobrazit plný text záznamu
5
Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain
Autor: W. Eschner, Frank Jessen, Marc Warnecke, Hans Herzog, Michael J. Reinhardt, Joern Schmaljohann, Alexis Joe, Thomas Klockgether, Martina Minnerop, Christian G. Schütz, Ullrich Wüllner, Daniela Gündisch
Publikováno v: Neuroscience Letters. 430:34-37
The role of the alpha4beta2* nicotinic acetylcholine receptors (nAChR) in tobacco addiction in humans is largely unresolved. We visualized brain alpha4beta2* nicotinic acetylcholine receptors of smokers and non-smokers with positron emission tomograp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff6150883bac3a85fb1609e7a565d82
https://doi.org/10.1016/j.neulet.2007.10.011
Zobrazit plný text záznamu
6
Procedure guideline for radioiodine test (Version 3)
Autor: für die Deutsche Gesellschaft für Nuklearmedizin, Michael Lassmann, W. Eschner, Markus Dietlein, B. Leisner, J. Dressler, Harald Schicha, C. Reiners
Publikováno v: Nuklearmedizin. 46:198-202
SummaryThe version 3 of the procedure guideline for radioiodine test is an update of the guideline previously published in 2003. The procedure guideline discusses the pros and cons of a single measurement or of repeated measurements of the iodine-131
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed41cdeeaeaf81acc307c90b58671d7f
https://doi.org/10.1160/nukmed-0283
Zobrazit plný text záznamu
7
Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)
Autor: W. Eschner, B. Leisner, Christoph Reiners, Frank Grünwald, Markus Dietlein, Markus Luster, Otmar Schober, J. Dressler, Michael Lassmann, Ernst Moser, Harald Schicha
Publikováno v: Nuklearmedizin. 46:213-219
SummaryThe procedure guideline for radioiodine therapy (RIT) of differentiated thyroid cancer (version 3) is the counterpart to the procedure guideline for 131I whole-body scintigraphy (version 3) and specify the interdisciplinary guideline for thyro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::551d018f93048b17163f945a1a33e504
https://doi.org/10.1160/nukmed-0286
Zobrazit plný text záznamu
8
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Autor: Jan Pruim, Eric P. Visser, Arturo Chiti, Klaus Tatsch, Joerg Kotzerke, Ronald Boellaard, Bertjan Arends, Giorgio Testanera, Antoon T.M. Willemsen, Wolfgang A. Weber, Otto S. Hoekstra, Roberto Delgado-Bolton, Lucy Pike, Sigrid Stroobants, Bernd J. Krause, Dominique Delbeke, Scott Holbrook, Andreas Bockisch, Sally F. Barrington, Thomas Beyer, Francesco Giammarile, Michael M. Graham, Josée M. Zijlstra, Fred J. Verzijlbergen, Kevin J. Donohoe, W. Eschner, Corneline J. Hoekstra, Wim J.G. Oyen
Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, 2, pp. 328-354
European journal of nuclear medicine and molecular imaging
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328-354. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 328-354
STARTPAGE=328;ENDPAGE=354;ISSN=1619-7070;TITLE=European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328-354. Springer Verlag
Boellaard, R, Delgado-Bolton, R, Oyen, W J G, Giammarile, F, Tatsch, K, Eschner, W, Verzijlbergen, F J, Barrington, S F, Pike, L C, Weber, W A, Stroobants, S, Delbeke, D, Donohoe, K J, Holbrook, S, Graham, M M, Testanera, G, Hoekstra, O S, Zijlstra, J M, Visser, E, Hoekstra, C J, Pruim, J, Willemsen, A, Arends, B, Kotzerke, J, Bockisch, A, Beyer, T, Chiti, A & Krause, B J 2015, ' FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 2, pp. 328-354 . https://doi.org/10.1007/s00259-014-2961-x
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328-354. Springer-Verlag
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a comm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512b2812d39298ffc3a5e30629884b15
https://hdl.handle.net/2066/155253
Zobrazit plný text záznamu
9
Bildrekonstruktion und Quantifizierung in der Emissionstomographie
Autor: W. Eschner, Michael Mix
Publikováno v: Zeitschrift für Medizinische Physik. 16:19-30
Radionuclide tomographic imaging has substantially benefited from the introduction of statistical image reconstruction. Although the main concepts of these iterative algorithms were published decades ago, their widespread use in clinical routine only
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28b7ccb54fda120272863c1a0e32f499
https://doi.org/10.1078/0939-3889-00289
Zobrazit plný text záznamu
10
Is there a benefit of 131I-MIBG therapy in the treatment of children with stage 4 neuroblastoma?
Autor: W. Eschner, F. Sudbrock, Markus Dietlein, T. Simon, Harald Schicha, Matthias Schmidt, R. Bongartz, F Berthold, B. Hero
Publikováno v: Nuklearmedizin. 45:145-151
SummaryAim: 131I-meta-iodobenzylguanidine (131I-MIBG) therapy has been used in neuroblastoma treatment for many years but its value in high intensive first line treatment protocols is not exactly known. Patients, methods: Stage 4 neuroblastoma patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9d00d64bc1b2bf34e7b614b8a8986977
https://doi.org/10.1055/s-0038-1625111
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje